SAKAR logo

Sakar Healthcare Limited Stock Price

NSEI:SAKAR Community·₹12.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

SAKAR Share Price Performance

₹555.50
314.07 (130.09%)
₹555.50
314.07 (130.09%)
Price ₹555.50

SAKAR Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
1 Reward

Sakar Healthcare Limited Key Details

₹2.3b

Revenue

₹1.1b

Cost of Revenue

₹1.2b

Gross Profit

₹964.6m

Other Expenses

₹252.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
11.34
52.59%
10.90%
28.1%
View Full Analysis

About SAKAR

Founded
2004
Employees
342
CEO
Sanjay Shah
WebsiteView website
www.sakarhealthcare.com

Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analgesic, antihistamine, anthelmintic, anti-malarial, antibacterial, vitamins, antifungal, diuretics, oxytocic, antacid, laxative, anticoagulant, anaesthetic, bronchodilator, adrenergic, sedative, anti-inflammatory, antiemetic, anticonvulsant, antipsychotic, antidepressant, and anti-cancer. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

Recent SAKAR News & Updates

Recent updates

No updates